NFO period: 20^th June - 04^th July, 2019

Highlights of the NFO:

• Scheme type - An open ended equity scheme investing in Pharma and Healthcare Services Sector


• Investment objective - The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India. The scheme does not guarantee/indicate any returns. There can be no assurance that the schemes’ objectives will be achieved.


• Product suitability - The product is suitable for investors who are seeking long term capital growth by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.


• Minimum Application Amount - First investment is Rs. 1,000/- and in multiples of Rs. 1/- thereafter


• Plan/ Options available - Regular Plan and Direct Plan having Growth Option and Dividend Option (Payout & Reinvestment Facility).


• Fund Manager - Mr. Dhaval Shah


• Benchmark - S&P BSE Healthcare TRI